Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.
Vehreschild MJ, Weitershagen D, Biehl LM, Tacke D, Waldschmidt D, Töx U, Wisplinghoff H, Von Bergwelt-Baildon M, Cornely OA, Vehreschild JJ. Vehreschild MJ, et al. Among authors: wisplinghoff h. Biol Blood Marrow Transplant. 2014 Jun;20(6):823-8. doi: 10.1016/j.bbmt.2014.02.022. Epub 2014 Mar 6. Biol Blood Marrow Transplant. 2014. PMID: 24607558 Free article.
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
Vehreschild MJ, von Bergwelt-Baildon M, Tran L, Shimabukuro-Vornhagen A, Wisplinghoff H, Bangard C, Cornely OA, Vehreschild JJ. Vehreschild MJ, et al. Among authors: wisplinghoff h. Eur J Haematol. 2014 Nov;93(5):400-6. doi: 10.1111/ejh.12368. Epub 2014 May 26. Eur J Haematol. 2014. PMID: 24798021 Clinical Trial.
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis.
Wingen-Heimann SM, Cornely OA, Vehreschild MJGT, Wisplinghoff H, Franke B, Schons M, von Bergwelt-Baildon M, Scheid C, Vehreschild JJ. Wingen-Heimann SM, et al. Among authors: wisplinghoff h. Mycoses. 2021 Apr;64(4):437-444. doi: 10.1111/myc.13232. Epub 2021 Jan 6. Mycoses. 2021. PMID: 33354800
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole.
Heimann SM, Cornely OA, Wisplinghoff H, Kochanek M, Stippel D, Padosch SA, Langebartels G, Reuter H, Reiner M, Vierzig A, Seifert H, Vehreschild MJ, Glossmann J, Franke B, Vehreschild JJ. Heimann SM, et al. Among authors: wisplinghoff h. Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):331-8. doi: 10.1007/s10096-014-2230-8. Epub 2014 Sep 12. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25213718
Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.
Farowski F, Bücker V, Vehreschild JJ, Biehl L, Cruz-Aguilar R, Scheid C, Holtick U, Jazmati N, Wisplinghoff H, Cornely OA, Vehreschild MJGT. Farowski F, et al. Among authors: wisplinghoff h. Bone Marrow Transplant. 2018 Jan;53(1):52-57. doi: 10.1038/bmt.2017.203. Epub 2017 Nov 13. Bone Marrow Transplant. 2018. PMID: 29131156
FungiScope™ -Global Emerging Fungal Infection Registry.
Seidel D, Durán Graeff LA, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, Klimko N, Sheppard DC, Herbrecht R, Chowdhary A, Cornely OA, FungiScope Group. Seidel D, et al. Among authors: wisplinghoff h. Mycoses. 2017 Aug;60(8):508-516. doi: 10.1111/myc.12631. Mycoses. 2017. PMID: 28730644
102 results